Cat.#: ACPP-1329
| Despition | PDE6 Beta Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
| ACPP-1170 | GAPDH Blocking Peptide (AC1170) | 250 µg | inquiry |
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1388 | Human FDX1 Protein (AC1388) | 5 µg | inquiry |
| ACPP-1466 | Human ATG10 Protein (AC1466) | 5 µg | inquiry |
| ACPP-1638 | Human CNTF Protein (AC1638) | 5 µg | inquiry |
| ACPP-1645 | Human FAM84B Protein (AC1645) | 5 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.